Cells were lysed with
RIPA lysis buffer (Solarbio Biotechnology Beijing, Beijing, China) supplemented with 1 mM protease and phosphatase inhibitors. Protein concentrations were measured using the
BCA Protein Assay Kit (Solarbio Biotechnology Beijing, Beijing, China), separated with 6–15% SDS polyacrylamide gels, and then transferred to polyvinylidene difluoride (
PVDF) membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% skim milk for 1–2 h at room temperature and incubated at 4 °C overnight with different primary antibodies: AMPK (1:1000, Wanleibio, Shenyang, China, WL02254),
P-AMPK (Thr 172) (1:2000, Cell Signaling Technology, Danvers, MA, USA, #2531),
P-ACC (Ser79) (1:2000, Cell Signaling Technology, Danvers, MA, USA, #3661), ACC (1:2000, Cell Signaling Technology, Danvers, MA, USA, #3662), AKT (1:1000, Abcam, Cambridge, MA, USA), ab38449), P-AKT (Ser473) (1:1000, Wanleibio, Shenyang, China, WLP001a), Insulin Receptor (INSR) (1:500, Wanleibio, Shenyang, China, WL02857), and
GAPDH (1:2000, Cell Signaling Technology, Danvers, MA, USA, #5174S). The washed membranes were incubated with the corresponding secondary antibodies for 1–2 h. Finally, the signal was detected with bio rad Chemidoc Touch imager (Bio-Rad Chemidoc Touch, Hercules, CA, USA) using enhanced chemiluminescence kits (ECL, vazyme, Nanjing, China).
Huang C., Gao X., Shi Y., Guo L., Zhou C., Li N., Chen W., Yang F., Li G., Zhuang Y., Liu P., Hu G, & Guo X. (2022). Inhibition of Hepatic AMPK Pathway Contributes to Free Fatty Acids-Induced Fatty Liver Disease in Laying Hen. Metabolites, 12(9), 825.